Risk of hypoglycemia with sodium glucose cotransporter-2 inhibitors versus alternative glucose lowering medications in patients with and without baseline use of insulin or sulfonylurea

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2022)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要